Avid Bioservices Inc (CDMO)

[DrRocker]

This is indeed troubling and lends support to the theory that the FDA is in the pocket of some big BPs and are working in cahoots to slow Bavi's progress. With bavi's demonstrated safety profile and extraordinary MOS results achieved in 2nd line lung (pre or post dose switching)it is hard to understand why there would not be some type of accelerated or even immediate approval contingent on follow up phase three confirmative work. By granting only regular approval for the phase three trial the FDA has provded themselves with the needed cover to protect against accusations of corruption while simultaneously achieving the goal of slowing bavi's progress significantly IMO.